HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 319-328

  Wainwright, Shane D ^a   Biro, P Andrew ^b   Holmes, Christopher H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA F ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0033970459     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.319     Document Type: Article

References (50)

1. Koller, B. H., D. E. Geraghty, R. DeMars, L. Duvick, S. S. Rich, and H. T. Orr. 1989. Chromosomal organization of the human major histocompatibility complex class I gene family. J. Exp. Med. 169:469.
2. Geraghty, D.E. 1993. Structure of the HLA class I region and expression of its resident genes. Curr. Opin. Immunol. 5:3.
3. Bjorkman, P. J., and P. Parham. 1990. Structure, function and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:253.
4. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
5. Shawar, S. M., J. M. Vyas, J. R. Rodgers, and R. R. Rich. 1994. Antigen presentation by major histocompatibility complex class Ib molecules. Annu. Rev. Immunol. 12:839.
6. O'Callaghan, C. A., and J. I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163:129.
7. Stroynowski, I., and K. Fischer Lindahl. 1994. Antigen presentation by nonclassical class I molecules. Curr. Opin. Immunol. 6:38.
8. Lee, N., A. R. Malacko, A. Ishitani, M.-C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591.
9. Diehl, M., C. Münz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H. Rammansee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6:305.
10. Münz, C., N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H.-G. Rammensee. 1997. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185:385.
11. 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. USA 94:5249.
12. Wei, X., and H. T. Orr. 1990. Differential expression of HLA-E, HLA-F and HLA-G transcripts in human tissue. Hum. Immunol. 29:131.
13. Ulbrecht, M., T. Honska, S. Person, J. P. Johnson, and E. H. Weiss. 1992. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J. Immunol. 149:2945.
14. Ulbrecht, M., J. Kellerman, J. P. Johnson, and E. H. Weiss. 1992. Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J. Exp. Med. 176:1083.
15. 2microglobulin and allelic differences. Eur. J. Immunol. 29:537.
16. Soloski, M. J., A. DeCloux, C. J. Aldrich, and J. Forman. 1995. Structure and function of the class Ib molecule, Qa-1. Immunol. Rev. 147:67.
17. Braud, V., E. Y. Jones, and A. McMichael. 1997. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27: 1164.
18. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951.
19. Ulbrecht, M., S. Modrow, R. Srivastava, P. A. Peterson, and E. H. Weiss. 1998. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J. Immunol. 160:4375.
20. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795.
21. Lee, N., D. R. Goodlett, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199.
22. Geraghty, D. E., X. Wei, H. T. Orr, and B. H. Koller. 1990. Human leukocyte antigen F (HLA-F). J. Exp. Med. 171:1.
23. Lury, D., H. Epstein, and N. Holmes. 1990. The human class I MHC gene HLA-F is expressed in lymphocytes. Int. Immunol. 2:532.
24. Houlihan, J. M., P. A. Biro, A. Fergar-Payne, K. L. Simpson, and C. H. Holmes. 1992. Evidence for the expression of non-HLA-A, -B, -C class I genes in the human fetal liver. J. Immunol. 149:668.
25. Houlihan, J. M., P. A. Biro, H. M. Harper, H. J. Jenkinson, and C. H. Holmes. 1995. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J. Immunol. 154:5665.
26. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of the three cloned human non-HLA-A, B, C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85:227.
27. Braud, V. M., D. S. J. Allan, D. Wilson, and A. J. McMichael. 1998. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1.
28. McMaster, M. T., C. L. Librach, Y. Zhou, K.-H. Lim, M. J. Janatpour, R. Demars, S. Kovats, C. Damsky, and S. J. Fisher. 1995. Human placental HLA-G is restricted to differentiated cytotrophoblasts. J. Immunol. 154:3771.
29. McMaster, M. T., Y. Zhou, S. Shorter, K. Kapasi, D. Geraghty, K.-H. Lim, and S. Fisher. 1998. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J. Immunol. 160:5922.
30. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
31. Brodsky, F. M., P. Parham, C. J. Barnstable, M. J. Crumpton, and W. F. Bodmer. 1979. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47:3.
32. Ellis, S. A., C. Taylor, and A. J. McMichael. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5:49.
33. McMichael, A. J., P. R. Parham, N. Rust, and F. M. Brodsky. 1980. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and -B17. Hum. Immunol. 1:121.
34. 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol. 9:536.
35. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C products. J. Immunol. 137:2299.
36. 2-microglobulin: differential effects of glycosylation on class I subunit association. Eur. J. Immunol. 18:1101.
37. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.
38. Johnstone, A., and R. Thorpe. 1996. Immunochemistry in Practice, 3rd Ed. Blackwell Science, Oxford, p. 101.
39. Lopez de Castro, J. A. 1984. Purification of human HLA-A and HLA-B class I histocompatibility antigens. Methods Enzymol. 108:582.
40. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
41. Neefjes, J. J., I. Doxiadis, N. J. Stam, C. J. Beckers, and H. L. Ploegh. 1986. Analysis of class I antigens of man and other species by one-dimensional IEF and immunoblotting. Immunogenetics 23:164.
42. Kao, K.-J., and W. A. Riley. 1993. Genetic predetermination of quantitative expression of HLA antigens in platelets and mononuclear leukocytes. Hum. Immunol. 38:243.
43. Benham, A. M., M. Grommé, and J. Neefjes. 1998. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J. Immunol. 161:83.
44. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B -C genes using an HLA-A, -B, -C null cell line. J. Immunol. 142:3320.
45. Wainwright, S. D., K. L. Simpson, and C. H. Holmes. 1998. Calreticulin associates with non-HLA-A, -B class I proteins in the human choriocarcinoma cell lines JEG-3 and BeWo. Immunology 93:437.
46. Schumacher, T. N. M., M.-T. Heemels, J. J. Neefjes, W. M. Kast, C. J. Melief, and H. L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563.
47. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103.
48. Burmeister, W. P., L. N. Gastinel, N. E. Simister, M. L. Blum, and P. J. Bjorkman. 1994. The 2.2 Å resolution crystal structure of the MHC-related neonatal Fc receptor. Nature 372:336.
49. + T cells. Nature 372:891.
50. Neisig, A., C. J. M. Melief, and J. Neefjes. 1998. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160:171.